Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy.
Sign Up to like & getrecommendations! Published in 2022 at "European urology"
DOI: 10.1016/j.eururo.2022.01.043
Abstract: Immune checkpoint inhibitor therapy improves survival in patients with metastatic renal cell carcinoma (RCC) but has not been studied well preoperatively in patients with localized disease undergoing nephrectomy. We conducted a single-center study to evaluate… read more here.
Keywords: nivolumab patients; renal cell; cell carcinoma; neoadjuvant nivolumab ... See more keywords
Neoadjuvant Nivolumab Checks Lung Cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nb2018-049
Abstract: The PD-1 inhibitor nivolumab given prior to surgical removal of early-stage non-small cell lung cancer is safe and produces a high rate of pathologic response, especially among those with high tumor mutation burden. read more here.
Keywords: checks lung; nivolumab checks; neoadjuvant nivolumab; lung cancer ... See more keywords
Neoadjuvant nivolumab monotherapy in patients with resectable gastric cancer: Preliminary results from a multicenter study.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.4026
Abstract: 4026Background: In recent years, several studies suggest that neoadjuvant treatment improve outcomes of patients with resectable advanced gastric cancer (GC). In addition, nivolumab has demonstrate... read more here.
Keywords: patients resectable; neoadjuvant nivolumab; monotherapy patients; gastric cancer ... See more keywords
Neoadjuvant Nivolumab and Chemotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Retrospective Study
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Management and Research"
DOI: 10.2147/cmar.s344343
Abstract: Background Patients with locally advanced (stage III) non-small cell lung cancer (NSCLC) demonstrate broad anatomic heterogeneity with modest survival benefits. Immune checkpoint inhibitors (ICIs) have shown survival benefit in metastatic NSCLC. We conducted this study… read more here.
Keywords: locally advanced; non small; neoadjuvant nivolumab; patients locally ... See more keywords
Neoadjuvant nivolumab with chemotherapy: A miraculous new regime in treatment of resectable lung cancers.
Sign Up to like & getrecommendations! Published in 2022 at "JPMA. The Journal of the Pakistan Medical Association"
DOI: 10.47391/jpma.6912
Abstract: Madam, lung cancer is one of the commonly diagnosed causes of cancer mortality and morbidity worldwide, accounting for approximately 1.76 million deaths annually.1 In the past overall survival in patients with non-small cell lung cancer… read more here.
Keywords: nivolumab chemotherapy; neoadjuvant nivolumab; chemotherapy alone; lung ... See more keywords